This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 6 and 12
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This is a randomized, double-blind, placebo-controlled, multicenter, 5-arm, parallel-group, fixed dose study to assess the efficacy and safety of SPN-812 ER in treatment of children aged 6-12 years with ADHD. The primary objective is to assess the effect of SPN-812 ER in reducing ADHD symptoms. This will be measured using the ADHD-RS-IV rating scale.

Provided treatments

  • Drug: Placebo
  • Drug: SPN-812 ER, Low Dose
  • Drug: SPN-812 ER, Low-Medium Dose
  • Drug: SPN-812 ER, High-Medium Dose
  • Drug: SPN-812 ER, High Dose

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02633527. The sponsor of the trial is Supernus Pharmaceuticals, Inc. and it is looking for 222 volunteers for the current phase.
Official trial title: